Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05251116 · ClinicalTrials.gov registry record · NA
Study of an Interstitial Fluid Glucose Sensor
A NA study of Diabete Mellitus, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 332
- Enrollment target
- 5
- Study locations
NCT05251116 is a NA study of Diabete Mellitus that has completed, run by Abbott Diabetes Care. The registered enrollment target is 332 participants, above the 153-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (117% higher). The trial reports 5 study locations across 5 states.
The verdict
NCT05251116, a NA study of Diabete Mellitus, has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
- 5
- Study locations
Study Summary
To characterize the System performance with respect to Yellow Springs Instrument (YSI) reference venous plasma measurements. Safety of the investigational device will be characterized by Adverse Device Effects and Serious Adverse Device Effects experienced by study participants.
Conditions Studied
Interventions
- DEVICE FreeStyle Libre
Study Locations (5)
California
- Sansum Diabetes Research Institute - Santa Barbara
Georgia
- Atlanta Diabetes Associates - Atlanta
Idaho
- Rocky Mountain Diabetes & Osteoporosis Center - Idaho Falls
Texas
- Diabetes and Glandular Disease Clinic - San Antonio
Washington
- Rainier Clinical Research - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2021-12-11 |
| Est. Completion | 2022-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05251116
The ClinicalTrials.gov registry entry for NCT05251116 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 153-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (117% higher). The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabete Mellitus appearing as the primary indexed condition, and to 1 intervention - of which FreeStyle Libre is the first listed.
NCT05251116 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Georgia, Idaho.
Frequently Asked Questions
What is clinical trial NCT05251116 about?
NCT05251116 is a clinical study titled "Study of an Interstitial Fluid Glucose Sensor". To characterize the System performance with respect to Yellow Springs Instrument (YSI) reference venous plasma measurements. Safety of the investigational device will be characterized by Adverse Device Effects and Serious Adverse Device Effects experienced by study participants.
What is the current status of trial NCT05251116?
This trial is currently completed. It is a NA study. The enrollment target is 332 participants. The study started on 2021-12-11. Estimated completion is 2022-08-15.
What conditions does trial NCT05251116 study?
This clinical trial studies the following conditions: Diabete Mellitus.
What interventions are being tested in trial NCT05251116?
The interventions under investigation include: FreeStyle Libre (DEVICE).
Who is sponsoring clinical trial NCT05251116?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05251116 being conducted?
This trial has 5 study locations across California, Georgia, Idaho, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabete Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
RECRUITING · NA
-
FSL2 Post Approval Study for Pediatric and Young Adults Patients
RECRUITING
-
Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing
RECRUITING · Phase 4
-
An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes
COMPLETED
-
StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
COMPLETED
-
FreeStyle Libre Flash Glucose Monitoring System Accuracy
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.